Welmate Famotidine 20mg
- Product NDC
- 73581-109
- 11-digit product format
- 735810109
- Labeler code
- 73581
- Product ID
- 73581-109_3b0b6d43-f858-3961-e063-6394a90af156
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Famotidine 20mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- YYBA Corp
- Application
- ANDA215822
- Marketing category
- ANDA
- Marketing start
- 2024-08-01
- Substance
- FAMOTIDINE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Welmate Famotidine 20mg
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 310273 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73581-109-01 | Welmate Famotidine 20mg | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 73581-109-20 | Welmate Famotidine 20mg | 300 in 1 BOTTLE | TABLET | 300 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73581-109 | WELMATE FAMOTIDINE 20MG (FAMOTIDINE 20MG) TABLET [YYBA CORP] | 1 | Current NDC, 2 package rows | 20240802_1ea3c6b6-4c1e-d93c-e063-6394a90a0dac.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 73581-109-01 | 73581010901 | 100 TABLET in 1 BOTTLE (73581-109-01) | 100 tablet | 2025-06-01 | No | No | Current |
| 73581-109-20 | 73581010920 | 300 TABLET in 1 BOTTLE (73581-109-20) | 300 tablet | 2024-08-01 | No | No | Current |